An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors

E-ISSN： 1875-533x|24|23|2496-2504

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.23, 2017-09, pp. : 2496-2504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lysine-specific demethylase 1 as a potential therapeutic target

By Stavropoulos Pete Hoelz André

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 809-820

Informa Healthcare

Access to resources Recommend Favorite

Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2179-2188

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1- Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1874-1898

Bentham Science Publishers

Access to resources Recommend Favorite

LSD1 inhibition: a therapeutic strategy in cancer?

By Lynch James T Harris William J Somervaille Tim C P

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1239-1249

Informa Healthcare

Access to resources Recommend Favorite

Computational Methods in the Discovery and Design of BACE-1 Inhibitors

Current Medicinal Chemistry, Vol. 19, Iss. 36, 2012-12 ,pp. : 6095-6111

Bentham Science Publishers

Access to resources Recommend Favorite